"/>With the development of e-cigarettes, there are growing concerns about harmful chemicals and environmental damage.
VPLUS now returns to its roots, focusing on lung health through medical atomization. We have revolutionized the healthier nicotine ingestion experience with No Heat No Burn (NHNB), we have created a world without secondhand smoke, the destiny of e-cigarettes has been fulfilled, we deliver the Dosing - a third way of administering medicine to mankind, so V PLUS, NHNB was created for this purpose.
Years of experience
R&D Team
Certificates & Patents
Own Factory
At VPLUS, our foundation is built locally in USA to empower your business. VPLUS proudly operate state-of-the-art manufacturing facilities in the United States, establishing a new standard for reliability and excellence in the vaping industry.
This strategic choice to be "Built in the USA" is at the core of our promise to you. It translates into a seamless and responsive supply chain, free from the complexities of international logistics. By producing domestically, VPLUS ensures rigorous quality control at every step, foster agile innovation to meet market needs, and guarantee predictable delivery timelines.
The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP).
November 17th, 20251. Medical Background of Atomizers Atomization technology has long been applied in the medical field, particularly in the treatment of respiratory conditions such as asthma and COPD. By converting active compounds into ultra-fine particles, atomizers deliver substances directly to the lungs for rapid absorption and high bioavailability.
August 1st, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025The number of older Americans using vaping marijuana has nearly doubled in the past three years, according to new research supported by the American Association of Retired Persons (AARP).
November 17th, 2025Introduction As healthcare providers in the U.S. increasingly seek effective, reimbursable methods to help patients quit smoking, water-based nicotine inhalation products are emerging as a powerful new solution. These formulations offer both clinical effectiveness and regulatory advantages—making them ideal for pharmacy and clinic distribution under Medicare-supported cessation programs. Medicare Covers Up to $2,000 Per Patient […]
July 23rd, 2025Abstract Oil-based cannabinoids have long faced challenges such as low oral bioavailability (typically under 15%), poor formulation compatibility, and inconsistent onset. Water-based delivery systems—THCX, and RENICO—offer a new standard of performance, combining faster absorption, enhanced versatility, and broader consumer appeal. This article outlines the science and innovation behind these next-generation cannabinoid formats. The Limitations of
July 18th, 2025
